Incyte | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.73B 195M 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Exelixis USD 1.18B 215.74M 2025-07
Gilead Sciences USD 14.72B 2.18B 2025-06
Incyte USD 3.64B 411.91M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 37.07B 1.56B 2025-06
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 43.7B 2.16B 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Incyte Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.